Population based prostate cancer screening in north Mexico reveals a high prevalence of aggressive tumors in detected cases

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Gomez Guerra, Lauro S ^a   Martinez Fierro, Margarita L ^a   Alcantara Aragon, Valeria ^a   Ortiz Lopez, Rocio ^a   Martinez Villarreal, Rebeca T ^a   Morales Rodriguez, Idelma B ^a   Garza Guajardo, Raquel ^a   Ponce Camacho, Marco A ^a   Rojas Martinez, Augusto ^a  

^a UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; DISEASE SEVERITY; FOLLOW UP; GLEASON SCORE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEXICO; POPULATION RESEARCH; PREVALENCE; PRIMARY MEDICAL CARE; PROSTATE BIOPSY; PROSTATE CANCER; URBAN POPULATION; BIOPSY; BLOOD; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSTATE; PROSTATE TUMOR; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STATISTICS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DIGITAL RECTAL EXAMINATION; HUMANS; MALE; MASS SCREENING; MEXICO; MIDDLE AGED; PREVALENCE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URBAN POPULATION;

EID: 64749089764     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-91     Document Type: Article

References (16)

1. Sistema Nacional de Información en Salud: Base de datos 2005 http://sinais.salud.gob.mx/mortalidad/
2. Programa de Acción: Cáncer de Próstata. Centro Nacional de Vigilancia Epidemiológica. Secretaría de Salud de México 2001 http://bibliotecas.salud.gob.mx/gsdl/collect/ publin1/index/assoc/HASH18a3.dir/doc.pdf
3. Harris R Lohr KN Screening for prostate cancer: An update of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 2002, 137(11):917-929. 12458993
4. Krahn MD Mahoney JE Eckman MH Trachtenberg J Pauker SG Detsky AS Screening for prostate cancer. A decision analytic view JAMA 1994 272(10):773-780. 10.1001/jama.272.10.773 7521400
5. Kramer BS Brown ML Prorok PC Potosky AL Gohagan JK Prostate cancer screening: What we know and what we need to know Ann Intern Med 1993, 119(9):914-923. 7692780
6. Society AC Detailed guide: Prostate cancer http://www.cancer.org/docroot/ CRI/content/CRI_2_4_3X_Can_prostate_cancer_be_found_early_36.asp
7. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 2008, 149(3):185-191. 2008/08/06 edition 18678845
8. Hoedemaeker RF Kwast van der TH Boer R de Koning HJ Roobol M Vis AN Schroder FH Pathologic features of prostate cancer found at population-based screening with a four-year interval J Natl Cancer Inst 2001, 93(15):1153-1158. 10.1093/jnci/93.15.1153 11481387
9. Roobol MJ Kranse R de Koning HJ Schroder FH Prostate-specific antigen velocity at low prostate-specific antigen levels as screening tool for prostate cancer: results of second screening round of ERSPC (ROTTERDAM) Urology 2004, 63(2):309-313. discussion 313-305. 10.1016/ j.urology.2003.09.083 14972478
10. Thompson IM Pauler DK Goodman PJ Tangen CM Lucia MS Parnes HL Minasian LM Ford LG Lippman SM Crawford ED et al Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4.0 ng per milliliter N Engl J Med 2004, 350(22):2239-2246. 10.1056/NEJMoa031918 15163773
11. Hedelin H Johansson N Stroberg P Relationship between benign prostatic hyperplasia and lower urinary tract symptoms and correlation between prostate volume and serum prostate-specific antigen in clinical routine Scand J Urol Nephrol 2005, 39(2):154-159. 10.1080/00365590510007685 16019770
12. Simardi LH Tobias-MacHado M Kappaz GT Taschner Goldenstein P Potts JM Wroclawski ER Influence of asymptomatic histologic prostatitis on serum prostate-specific antigen: a prospective study Urology 2004, 64(6):1098-1101. 10.1016/j.urology.2004.08.060 15596176
13. Pannek J Marks LS Pearson JD Rittenhouse HG Chan DW Shery ED Gormley GJ Subong EN Kelley CA Stoner E et al Influence of finasteride on free and total serum prostate specific antigen levels in men with benign prostatic hyperplasia J Urol 1998, 159(2):449-453. 10.1016/ S0022-5347(01)63946-6 9649261
14. Eskew LA Bare RL McCullough DL Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate J Urol 1997, 157(1):199-202. discussion 202-193. 10.1016/ S0022-5347(01)65322-9 8976250
15. Brossner C Madersbacher S Bayer G Pycha A Klingler HC Maier U Comparative study of two different TRUS-guided sextant biopsy techniques in detecting prostate cancer in one biopsy session Eur Urol 2000, 37(1):65-71. 10.1159/000020102 10671788
16. Stamatiou K Alevizos A Karanasiou V Mariolis A Mihas C Papathanasiou M Bovis K Sofras F Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer Urol Int 2007, 78(4):313-317. 10.1159/000100834 17495488